Na+/H+ exchanger activity is increased in doxorubicin‐resistant human colon cancer cells and its modulation modifies the sensitivity of the cells to doxorubicin
Open Access
- 23 February 2005
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 115 (6) , 924-929
Abstract
Multidrug resistant (MDR) tumor cells exhibit an altered pH gradient across different cell compartments, which favors a reduced intracellular accumulation of antineoplastic drugs and a decreased therapeutic effect. In our study, we have observed that the activity and expression of Na+/H+ exchanger (NHE), which is involved in the homeostasis of intracellular pH (pHi), are increased in doxorubicin‐resistant (HT29‐dx) human colon carcinoma cells in comparison with doxorubicin‐sensitive HT29 cells. The pHi was significantly higher in HT29‐dx cells, which accumulated less doxorubicin than HT29 cells. The NHE inhibitor 5‐(N‐ethyl‐N‐isopropyl)amiloride (EIPA) significantly reduced the pHi value and increased the intracellular accumulation of doxorubicin in both cell populations: in the presence of EIPA HT29‐dx cells accumulated as much drug as control HT29 cells. On the other hand, monensin, a Na+/H+ ionophore mimicking NHE activation, and phorbol 12‐myristate 13‐acetate (PMA), which stimulates NHE, significantly increased the pHi and decreased the drug accumulation in HT29 cells to values similar to those observed in control HT29‐dx cells. EIPA potentiated the cytotoxic effect of doxorubicin in HT29 cells, and made HT29‐dx cells as sensitive to the cytotoxic effect of the drug as control HT29 cells. Instead, PMA and monensin made HT29 cells as insensitive to doxorubicin as HT29‐dx cells. These results suggest that in MDR cells the higher cytosolic pH is likely to decrease drug accumulation, and that such resistance can be reverted by inhibiting the NHE activity. This result opens the possibility to revert MDR with the clinical use of NHE inhibitors.Keywords
This publication has 32 references indexed in Scilit:
- Ethyl isopropyl amiloride inhibits smooth muscle cell proliferation and migration by inducing apoptosis and antagonizing urokinase plasminogen activator activityCanadian Journal of Physiology and Pharmacology, 2003
- An overview of inhibitors of Na+/H+ exchangerEuropean Journal of Medicinal Chemistry, 2003
- Zoniporide: A Potent and Selective Inhibitor of the Human Sodium‐Hydrogen Exchanger Isoform 1 (NHE‐1)Cardiovascular Drug Reviews, 2003
- The Changing Face of the Na+/H+ Exchanger, NHE1: Structure, Regulation, and Cellular ActionsAnnual Review of Pharmacology and Toxicology, 2002
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Role of organelle pH in tumor cell biology and drug resistanceDrug Discovery Today, 1999
- Reversal of doxorubicin resistance by the amiloride analogue EIPA in multidrug resistant human colon carcinoma cellsCell Biochemistry and Function, 1996
- Cytotoxicity of oxidants and asbestos fibers in cultured human mesothelial cellsFree Radical Biology and Medicine, 1994
- Role of Intracellular pH in Mammalian Cell ProliferationCellular Physiology and Biochemistry, 1992
- Involvement of Vacuolar H+-Adenosine Triphosphatase Activity in Multidrug Resistance in HL60 CellsJNCI: Journal of the National Cancer Institute, 1991